MOUNTAIN VIEW, Calif.--(EON: Enhanced Online News)--DNAnexus Inc., the global leader in genome informatics and data management, today announced two significant additions to the company’s executive leadership team. Brady Davis has joined the company as vice president, strategy and marketing, and John Ellithorpe, Ph.D. has joined as chief product officer. Richard Daly, chief executive officer of DNAnexus, will provide additional details and a corporate update in his presentation at the 35th Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2017 at 2:00 p.m. PT.
“As we drive towards realizing the promise of precision medicine, researchers, clinicians, and biopharmaceutical R&D organizations will require increasingly more powerful, flexible, and secure analytical tools and technologies. I am thrilled to join this stellar team and use my expertise in advanced computing systems to support DNAnexus and their mission.”
Davis joins DNAnexus from Illumina where he led global product marketing for informatics, developed strategic partnerships and identified investment and acquisition opportunities. He joined Illumina from Oracle where he led business development, strategy and innovation for the Oracle Health Sciences Global Business Unit. Ellithorpe was co-founder, chief technology officer and chief product officer at Model N, a leading provider of revenue management solutions for the life sciences and technology industries. At Model N, he led the global products group and drove the company’s technical strategy. He joins DNAnexus from Vantiq where he was chief product officer.
"We are privileged to have leaders such as Brady and John join our team at this exciting time of expansion," said Daly. "Bringing on Brady and John further expands our strategic market development and product management capabilities, which will be vital as we continue to rapidly scale global commercial operations. I look forward to discussing these and other exciting company developments at the upcoming J.P. Morgan Healthcare Conference.”
For more than 15 years, Davis has been an innovator and leader across multiple segments of the healthcare ecosystem, including hospital, life sciences, consumer health and wellness. Davis was recently named co-chair of the Advisory Board for the University of Washington Center for Commercialization (C4C) focused on new ventures in healthcare as well as the Cancer Informatics for Cancer Centers (CI4CC) Board of Advisors. Davis holds a Bachelor of Arts and an Executive MBA from the University of Washington.
"DNAnexus has consistently demonstrated its leadership in helping research, biopharma and diagnostic organizations take advantage of the tremendous opportunities presented by the availability of large-scale genomic datasets," said Davis. “I am excited to join this incredible organization and am looking forward to expanding our existing collaborations with our customers and developing new opportunities for the company around the world.”
For more than 20 years, Ellithorpe has been focused on building distributed software platforms and complex computing systems for industrial businesses. Ellithorpe earned a Bachelor of Science in Physics from the University of California at Irvine and a Ph.D. in Physics from the Massachusetts Institute of Technology.
"DNAnexus is already an established and sophisticated genomics and translational medicine platform for scientists, researchers and the global life sciences industry," said Ellithorpe. "As we drive towards realizing the promise of precision medicine, researchers, clinicians, and biopharmaceutical R&D organizations will require increasingly more powerful, flexible, and secure analytical tools and technologies. I am thrilled to join this stellar team and use my expertise in advanced computing systems to support DNAnexus and their mission.”
DNAnexus combines expertise in computing and bioinformatics to create the global network for genomics, operating in North America, Europe, Asia-Pacific (including China), South America, and Africa. The secure, scalable, and collaborative DNAnexus Platform helps thousands of researchers across a spectrum of industries – biopharmaceutical, bioagricultural, sequencing services, clinical diagnostics, government, and research consortia – accelerate their genomics programs globally. For more information on DNAnexus, please visit www.dnanexus.com or follow the company @DNAnexus.